IAS International conference on atherosclerosis 2020

It’s been more than 100 years since Nikolay Anitschkow discovered and confirmed ”The cholesterol hypothesis“ and the journey to understand cholesterol, hyperlipidemias and dyslipidemias has taken many twists and turns, but the all signs point to Moscow in 2020. Clinicians will not be disappointed.

Along the way, several crossroads and milestones have been marked: The connection between FH and coronary heart disease, the discovery of lipid lowering drugs, the Lipid Research Clinics Coronary Primary Prevention Trial, the discovery of statins, the Nobel prize for LDL-R function description, the “4S” trial when clinical lipidology “was stolen” from metabolism to cardiology

Registration available online here

Programme available online here